LifeTech ScientificFRA:81X -0.71%96 FCF Margin % is 9.30% as of Dec. 2025, which is 9% below its 10-year median of 10.23. GuruFocus rates FRA:81X with a GF Score™ of 96/100 and a GF Value™ of €0.21. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, LifeTech Scientific ranks better than 96.93% on this metric.
The historical rank and industry rank for LifeTech Scientific's FCF Margin % or its related term are showing as below:
FRA:81X'
s FCF Margin % Range Over the Past 10 Years
Min: 0.48 Med: 10.23 Max: 29.13
Current: 29.09
During the past 13 years, the highest FCF Margin % of LifeTech Scientific was 29.13%. The lowest was 0.48%. And the median was 10.23%.
FRA:81X's FCF Margin % is ranked better than 96.93% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:81X: 29.09
LifeTech Scientific FCF Margin % Related Terms
LifeTech Scientific FCF Margin % Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's FCF Margin % distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (FRA:81X) has a FCF Margin % of 9.30% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LifeTech Scientific and its competitors. This is near median its historical median of 10.23. Over the past decade, LifeTech Scientific's FCF Margin % has ranged from 0.48 to 29.13. According to the industry distribution chart, LifeTech Scientific ranks #25 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 3.1%.
Is LifeTech Scientific's FCF Margin % too high?
LifeTech Scientific's current FCF Margin % of 9.30% is near median its 10-year median of 10.23. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 29.13. Based on the distribution chart, LifeTech Scientific ranks #25 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #25 out of 815 companies for FCF Margin %. This places LifeTech Scientific in the top 3% of its industry — outperforming the majority of peers. Historically, LifeTech Scientific's own FCF Margin % has ranged from 0.48 to 29.13 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on LifeTech Scientific and its competitors. LifeTech Scientific's current FCF Margin % is 9.30%, which is near median its own 10-year median of 10.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (FRA:81X) has a current FCF Margin % of 9.30%. The stock's GF Value™ is €0.21, compared to a current price of €0.14 — trading 33.3% below its estimated fair value. The current FCF Margin % is 9.30%, which is near median its 10-year median of 10.23. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For LifeTech Scientific (FRA:81X), the current FCF Margin % is 9.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (FRA:81X) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of €0.14 is trading 33.3% below its estimated GF Value™ of €0.21.
Key valuation signals for FRA:81X:
FCF Margin %: 9.30% (near median its 10-year median of 10.23)
GF Value™: €0.21 vs. price of €0.14 (33.3% below fair value)
No single metric tells the full story. See the FRA:81X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for FRA:81X
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:81X has been successfully added to your 
